Supplementary Figure Legends 1-3 from Antitumor Efficacy of the Novel RAF Inhibitor GDC-0879 Is Predicted by BRAF<sup>V600E</sup> Mutational Status and Sustained Extracellular Signal-Regulated Kinase/Mitogen-Activated Protein Kinase Pathway Suppression

Klaus P. Hoeflich,Sylvia Herter,Janet Tien,Leo Wong,Leanne Berry,Jocelyn Chan,Carol O'Brien,Zora Modrusan,Somasekar Seshagiri,Mark Lackner,Howard Stern,Edna Choo,Lesley Murray,Lori S. Friedman,Marcia Belvin

crossref（2023）

引用 0|浏览21

暂无评分

摘要

Supplementary Figure Legends 1-3 from Antitumor Efficacy of the Novel RAF Inhibitor GDC-0879 Is Predicted by BRAF^V600E Mutational Status and Sustained Extracellular Signal-Regulated Kinase/Mitogen-Activated Protein Kinase Pathway Suppression

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要

Supplementary Figure Legends 1-3 from Antitumor Efficacy of the Novel RAF Inhibitor GDC-0879 Is Predicted by BRAF&lt;sup&gt;V600E&lt;/sup&gt; Mutational Status and Sustained Extracellular Signal-Regulated Kinase/Mitogen-Activated Protein Kinase Pathway Suppression

Supplementary Figure Legends 1-3 from Antitumor Efficacy of the Novel RAF Inhibitor GDC-0879 Is Predicted by BRAF<sup>V600E</sup> Mutational Status and Sustained Extracellular Signal-Regulated Kinase/Mitogen-Activated Protein Kinase Pathway Suppression